OraSure Technologies Inc - Asset Resilience Ratio
OraSure Technologies Inc (OSUR) has an Asset Resilience Ratio of 0.00% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Also explore OSUR total assets for the complete picture of this company's asset base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1999–2023)
This chart shows how OraSure Technologies Inc's Asset Resilience Ratio has changed over time. See OraSure Technologies Inc net asset quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down OraSure Technologies Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see OSUR company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $-1.00 | -0.0% |
| Total Liquid Assets | $-1.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: OraSure Technologies Inc maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
OraSure Technologies Inc Industry Peers by Asset Resilience Ratio
Compare OraSure Technologies Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Hubei Huaqiang High-Tech Co. Ltd. A
SHG:688151 |
Medical Instruments & Supplies | 26.12% |
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
SWS Hemodialysis Care Co. Ltd. A
SHG:688410 |
Medical Instruments & Supplies | 38.45% |
|
Caina Technology Co. Ltd.
SHE:301122 |
Medical Instruments & Supplies | 19.74% |
|
IVF Hartmann Holding AG
SW:VBSN |
Medical Instruments & Supplies | 52.05% |
|
Dentium
KO:145720 |
Medical Instruments & Supplies | 1.23% |
|
Medeon Biodesign
TWO:6499 |
Medical Instruments & Supplies | 7.38% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
Annual Asset Resilience Ratio for OraSure Technologies Inc (1999–2023)
The table below shows the annual Asset Resilience Ratio data for OraSure Technologies Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.00% | $0.00 | $482.85 Million | -- |
| 2022-12-31 | 6.05% | $26.87 Million | $444.18 Million | -1.82pp |
| 2021-12-31 | 7.87% | $36.28 Million | $460.99 Million | -2.82pp |
| 2020-12-31 | 10.69% | $48.60 Million | $454.47 Million | -12.39pp |
| 2019-12-31 | 23.08% | $80.62 Million | $349.30 Million | +1.49pp |
| 2018-12-31 | 21.59% | $68.13 Million | $315.57 Million | -6.44pp |
| 2017-12-31 | 28.03% | $83.03 Million | $296.20 Million | +22.66pp |
| 2016-12-31 | 5.37% | $11.16 Million | $207.94 Million | +1.55pp |
| 2015-12-31 | 3.82% | $7.22 Million | $189.32 Million | +1.18pp |
| 2014-12-31 | 2.64% | $5.00 Million | $189.63 Million | -- |
| 2013-12-31 | 0.00% | $0.00 | $184.25 Million | -- |
| 2012-12-31 | 0.00% | $0.00 | $191.72 Million | -- |
| 2011-12-31 | 0.00% | $0.00 | $127.86 Million | -- |
| 2010-12-31 | 1.55% | $1.90 Million | $122.52 Million | -2.18pp |
| 2009-12-31 | 3.73% | $4.74 Million | $126.99 Million | -28.83pp |
| 2008-12-31 | 32.56% | $42.96 Million | $131.92 Million | -5.28pp |
| 2007-12-31 | 37.85% | $63.34 Million | $167.35 Million | -7.54pp |
| 2006-12-31 | 45.38% | $71.05 Million | $156.57 Million | +11.12pp |
| 2005-12-31 | 34.26% | $44.79 Million | $130.75 Million | -30.01pp |
| 2004-12-31 | 64.27% | $56.60 Million | $88.06 Million | +25.59pp |
| 2003-12-31 | 38.69% | $33.33 Million | $86.15 Million | +9.18pp |
| 2002-12-31 | 29.50% | $10.54 Million | $35.74 Million | -4.73pp |
| 2001-12-31 | 34.24% | $12.76 Million | $37.28 Million | -5.40pp |
| 2000-12-31 | 39.64% | $14.96 Million | $37.74 Million | -2.42pp |
| 1999-12-31 | 42.06% | $4.50 Million | $10.70 Million | -- |
About OraSure Technologies Inc
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapi… Read more